Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-02-22
2005-02-22
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S531000, C514S534000, C514S548000, C514S551000, C560S061000, C560S122000, C560S123000, C560S124000, C560S138000, C560S142000, C560S250000, C564S319000
Reexamination Certificate
active
06858650
ABSTRACT:
The present invention concerns highly pure, crystalline, stable compounds of novel derivatives of 3,3-diphenylpropylamines in the form of their salts, a method for the manufacture and highly pure, stable intermediate products.The method is in particular characterized by regio- and chemoselectivity and high yield. Salts of phenolic monoesters of 3,3-diphenylpropylamines are provided, that are particularly well-suited for use in pharmaceutical formulations. Preferred compounds are R-(+)-2-(3-diisopropylamino-1-phenyl-propyl)-4-hydroxymethylphenylisobutyrate ester hydrogen fumarate and R-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenylisobutyrate ester hydrochloride hydrate. Furthermore, stable, crystalline intermediate products that are essential for obtaining the abovementioned salts are provided. A preferred intermediate product is R-(−)-3-(3-diisopropylamino-phenyl-propyl)-4-hydroxy-benzoic acid methyl ester.
REFERENCES:
patent: 5686464 (1997-11-01), Johansson et al.
patent: 693 17 898 (1998-10-01), None
patent: 0 667 852 (1998-04-01), None
patent: 0 957 073 (1999-11-01), None
patent: 9411337 (1994-05-01), None
patent: 9843942 (1998-10-01), None
patent: 9958478 (1999-11-01), None
Nilvebrant et al, “Antimuscarinic Potency and Bladder Selectivity of PNU-200577, a Major Metabolite of Tolterodine” Pharmacology and Toxicology. vol. 81, pp. 169-172 (1997).*
L. Palmer, L. Andersson, T. Andersson, U. Stenberg:Determination of tolterodine and the 5-hydroxymethly metabolite in plasma, serum and urine using gas chromatography-mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis; Jan. 20, 1997; pp. 155-165.
Corless Peter F.
Edwards & Angell LLP
O'Day Christine C.
Raymond Richard L.
Schwarz Pharma AG
LandOfFree
Stable salts of novel derivatives of 3,3-diphenylpropylamines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable salts of novel derivatives of 3,3-diphenylpropylamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable salts of novel derivatives of 3,3-diphenylpropylamines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3470130